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Abstract
Background: Many marketed therapeutic agents have been developed to modulate the function
of G protein-coupled receptors (GPCRs). The regulators of G-protein signaling (RGS proteins) are
also being examined as potential drug targets. To facilitate clinical and pharmacological research,
we have developed a novel integrated biological database called RINGdb to provide comprehensive
and organized RGS protein and GPCR information.
Results:  RINGdb contains information on mutations, tissue distributions, protein-protein
interactions, diseases/disorders and other features, which has been automatically collected from
the Internet and manually extracted from the literature. In addition, RINGdb offers various user-
friendly query functions to answer different questions about RGS proteins and GPCRs such as their
possible contribution to disease processes, the putative direct or indirect relationship between
RGS proteins and GPCRs. RINGdb also integrates organized database cross-references to allow
users direct access to detailed information. The database is now available at http://
ringdb.csie.ncu.edu.tw/ringdb/.
Conclusion: RINGdb is the only integrated database on the Internet to provide comprehensive
RGS protein and GPCR information. This knowledgebase will be useful for clinical research, drug
discovery and GPCR signaling pathway research.
Background
G protein-coupled receptors (GPCRs), which represent
the largest family of cell-surface receptors, mediate a vari-
ety of extracellular signals, modulating many intracellular
responses [1]. A wide variety of GPCRs control the activity
of enzymes, ion channels and transport of vesicles via the
catalysis of the GDP-GTP exchange on heterotrimeric G
proteins (Gα-βγ), the key players in transmembrane sign-
aling [2,3]. Signal-induced conformational changes
enhance the guanine-nucleotide-exchange activity of the
receptor, leading to the release of GDP (and subsequent
binding of GTP) by the Gα subunit [2]. On binding GTP,
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conformational changes of Gα allow the release of Gβγ
and the subsequent engagement of effectors that are spe-
cific to each Gα subtype [2]. GPCRs are extremely impor-
tant because 50% of all currently marketed drugs have
action on specific GPCRs [4]. However, only 10% of
GPCRs are targeted by these drugs, emphasizing the
potential of the remaining 90% of the members of the
GPCR superfamily for the treatment of human diseases
[5]. Tissue-specific expression coupled with the availabil-
ity of highly selective ligands determines the physiological
roles of GPCRs [4]. Information regarding the localization
of GPCR and signaling/regulatory molecules, signaling
pathways, and the relationship between GPCR signaling
and diseases/disorders facilitates the identification of drug
targets and the development of drugs.
In addition to GPCRs and G-proteins, a family of signal
modulators (the regulators of G protein signaling or RGS
proteins) shows more restricted expression. These pro-
teins are being examined as potential drug targets. RGS
proteins are a large family of signaling proteins and share
a conserved signature domain (RGS domain) that directly
binds and activates G-alpha subunits, modulating G pro-
tein signaling. The major role of RGS proteins is to act as
Gα GTPase-accelerating proteins (GAPs). They reduce
GPCR signaling by accelerating the rate of GTP hydrolysis
by the G-protein α-subunit, which leads to Gα-Gβγ reas-
sociation [6]. Inhibiting the binding of the RGS-box to
Gα•GTP in this case would lead to a prolonged lifetime of
the Gα subunit in the GTP-bound state, enhancing the
GPCR-stimulated response through increased levels of
free Gα￿GTP and Gβγ subunits [7]. Recent findings indi-
cate that RGS proteins not only regulate G proteins but
also bind to other signaling modulators [7]. At least 20
proteins (besides G-alpha subunits) have now been iden-
tified as direct binding partners for RGS proteins, and
additional binding partners remain to be found [4]. Many
RGS proteins that bind non-G protein signaling partners
are expressed exclusively in specific brain regions [8,9],
which agrees with the extensive diversity of neuronal and
glial GPCRs and the signal modulation required for
proper brain function [4], making these proteins attractive
targets for possible therapeutic intervention. Evidence
also indicates that RGS proteins are able to directly bind
to GPCRs [4]. For example, the PDZ domain of RGS12
interacts specifically with the interleukin-8 receptor
(CXCR2) [10]. RGS proteins may stabilize an active
GPCR/G protein/channel complex to limit the diffusion
time necessary for activation and deactivation [11,12].
Given the highly restricted expression of RGS proteins and
the changes in levels of RGS proteins in response to vari-
ous disease states [5], understanding the part that RGS
proteins play as direct links between G proteins and other
signaling pathways and their possible contribution to dis-
ease processes are important research goals [4]. However,
little is known about the native tissue distribution and
physiological functions of all RGS proteins and about the
physiological significance of the interaction between RGS
proteins and other signaling molecules [4]. Although cur-
rent databases such as GPCRDB [13] and gpDB [14] pro-
vide information on GPCRs and/or G-proteins, there is
not a comprehensive database that provides information
on RGS, G-proteins, GPCRs, and the relationship between
GPCR signaling and diseases/disorders.
To address this matter, we have developed an integrated
biological database to provide complete and organized
RGS/GPCR information. A knowledgebase that deposits
the integrated RGS/GPCR data will be very useful for clin-
ical research, drug discovery and GPCR signaling pathway
research.
Construction and content
Data sources and contents
The RINGdb is a relational database implemented by
MySQL on Linux operation system. We use the Apache
web server and the PHP5 server side script engine. The
web pages and all data parsers are written in PHP and Perl,
respectively. Figure 1 shows the simplified relational
scheme of our database. For example, each core protein,
RGS protein or GPCR, in our database may interact with
one or many proteins, have more than one known
domains, distribute in various tissues, contribute to differ-
ent diseases/disorders, have many artificial mutants or
polymorphisms and could be referred to all kinds of pub-
lic databases.
The RINGdb contains all types of information about
mutations, tissue distributions, protein sequences, pro-
tein domains, post-translational modifications, protein-
protein interactions, diseases/disorders, drugs and lig-
ands. Most RGS protein information and GPCR diseases/
disorders information is extracted from MEDLINE
abstracts and full text papers (if available) by manual sur-
veys. The informative sentences extracted from the litera-
ture are provided. The following lists are the major
contents in RINGdb.
(i) The RGS protein mutation  information is extracted
from literature surveys. It describes what functional
changes occur upon RGS mutations and provides muta-
tion site information. GPCR mutation data have been pri-
marily collected from GPCRDB [13]. GPCR mutation
types, including mainly polymorphisms and laboratory
artificial modifications, are also annotated but most RGS
mutation data currently stored in RINGdb is generated by
site-directed mutagenesis.
(ii) The tissue distribution data describes RGS/GPCR tissue
specificity, distribution and expression. It is collectedBMC Genomics 2006, 7:317 http://www.biomedcentral.com/1471-2164/7/317
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from the literature, Swiss-Prot [15], SOURCE [16] and
GXD [17]. Tissue distribution information regarding RGS
proteins was mainly retrieved from the literature. We also
integrated Gene Expression Omnibus (GEO) [18] to our
system as database cross-reference.
(iii) All RGS protein and GPCR sequence data is automati-
cally retrieved from the Swiss-Prot database and only the
protein sequences annotated by Swiss-Prot as standards
are stored in RINGdb. At present, 2275 GPCR sequences
and 109 RGS protein sequences are available in RINGdb.
And most RGS proteins collected from Swiss-Prot belong
to mammalian especially human, mouse and rat.
(iv) The protein domain data is collected from a literature
survey, Pfam [19] and InterPro [20]. The literature derived
domain information describes the potential RGS/non-
RGS domain functions. The domain data extracted from
Pfam and InterPro contains domain descriptions as well
as their boundaries in RGS protiens or GPCRs. Most of the
non-RGS domains of RGS proteins could confer addi-
tional functions regarding either the regulation of RGS
proteins or the manner in which RGS proteins regulate
The simplified relational scheme of RINGdb Figure 1
The simplified relational scheme of RINGdb. Each gray box represents an entity with various attributes. Most entities in 
our databases could be classified into five categories, Core protein, Interaction, Medicine, Tissue expression and Database Cross-Ref-
erence. For instance, each RGS protein may contribute to one or more Diseases/Disorders or not be discovered to relate to 
any Diseases/Disorders yet.BMC Genomics 2006, 7:317 http://www.biomedcentral.com/1471-2164/7/317
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effectors [5]. For inferring putative RGS binding proteins,
we extract all putative domains interacting with the
domains in RGS proteins from InterDom [21].
(v) The post-translational modification (PTM) data is
extracted from the literature and Swiss-Prot. It contains
information regarding modification sites, types and the
description of the functional relationships between pro-
teins and PTM.
(vi) The protein-protein interaction data about RGS proteins
is obtained from literature surveys. It provides informa-
tion on binding sites, binding partners and descriptions of
the relationships between the protein and its binding
partners. At present, 308 RGS-protein interaction entries
are deposited in RINGdb. The size of protein-protein
interaction data about RGS is much greater than that
found in BIND [22], DIP [23] and MINT [24]. The num-
bers of RGS protein-protein interactions included in
BIND, DIP and MINT are 38, 0 and 56. For inferring the
relationship between GPCRs and RGS proteins, we also
integrate GPCR and G-alpha protein interaction informa-
tion from gpDB to RINGdb.
(vii) The diseases/disorders  data is obtained through a
search of the original literature. It contains information
that describes the relationships between diseases/disor-
ders and RGS proteins or GPCRs. Detailed disease infor-
mation including disease definitions, syndromes and
treatments is provided and the possible contribution of
RGS proteins and GPCRs to certain disease processes is
retrievable.
(viii) The ligand data automatically collected from KEGG
[25] is available in RINGdb. It shows the names of GPCR
ligands and the links to KEGG for examining detailed lig-
and information. We also provide the human, mouse and
rat orphan receptor lists extracted from Swiss-Prot.
All the data deposited in RINGdb is focused on mammals
including human, mouse and rat. For references available
in PubMed, the links are provided. Furthermore, in the
GPCR search page we provide links to GPCR classification
methods, such as GPCRpred [26] and PRED-GPCR [27].
Database cross-reference
For each RGS protein and GPCR, database cross-refer-
ences are provided. The integration into the RINGdb sys-
tem allows direct access to detailed information. All cross-
references are classified into seven categories including
Gene, Protein Domain, Medical, Protein-Protein Interac-
tion, Pathway, Classification and Others. Basic introduc-
tion for the cross-referenced databases or resources is
available when a mouse hovers over a link. This friendly
interface allows RINGdb access and utility.
Utility
Query method
RINGdb provides an integrated, classified and user-
friendly web interface for data query. Through the search
and navigation page, users can perform several searches
regarding particular RGS protein or GPCR entry by Pro-
tein Name/Keyword, Gene Name, Swiss-Prot ID and
Swiss-Prot accession number. All queries are primarily
classified into seven categories made up of: (i) General;
(ii) Disease; (iii) Mutation; (iv) Tissue Distribution; (v)
Protein-Protein Interaction; (vi) Protein Domain; (vii)
Post-Translational Modification. In addition, users can
navigate RGS proteins or GPCRs according to their pro-
tein families.
In order to retrieve disease information regarding the
human RGS2 protein, for example, the user can specify
'Gene Name' search type, select 'Human' species, input
RGS2 as the search term, choose 'Disease' information
option and then press the send button. All diseases/disor-
ders information involving the RGS2 protein can then be
retrieved. The users may also select a particular disease/
disorder such as Alzheimer's disease to find related RGS
proteins or GPCRs. To find tissue distribution for human
serotonin receptor 2B but not know its exact gene or pro-
tein name, as another example, the user is able to input
the keyword 'serotonin' as search term, to choose 'Protein
Name/Keyword' search type and to select the 'Tissue Dis-
tribution' information option. The returned page contains
all GPCRs with the 'serotonin' keyword. The user then can
click serotonin receptor 2B's gene name, HTR2B, for tissue
distribution information. Not only does the user find tis-
sue distribution information about RGS protein or
GPCRs, but it is also possible to identify in which tissue
both are co-expressed by 'Other Tissue Distribution infor-
mation' search.
Inference of the relationship between RGS proteins and 
GPCRs
In addition to comprehensive data query, one of most val-
uable aspects of the information available in RINGdb is
the ability to infer the relationships between RGS proteins
and GPCRs. If a RGS protein and GPCR both contribute
to some diseases, participate in specific signaling path-
ways and have similar tissue distributions, they are likely
to share a common functional role. Figure 2 shows the
inference processes of the relationships among RGS pro-
teins, GPCRs, Gα subunits and diseases/disorders. Users
are able to search the interaction between the signaling
molecules and find that both of RGS4 and CHRM1, the
muscarinic cholinergic receptor M1 for the neurotrans-
mitter acetylcholine, regulate the activity of the Gα q-
linked pathway. In addition, according to the results of
disease/disorder queries, users can find that both of them
possibly related to Alzheimer's disease. Furthermore, theyBMC Genomics 2006, 7:317 http://www.biomedcentral.com/1471-2164/7/317
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are both expressed in the hippocampus, a part of the ver-
Inferring relationships among GPCRs, Gα and RGS proteins for specific disease states Figure 2
Inferring relationships among GPCRs, Gα and RGS proteins for specific disease states. The relationship among 
GPCR, Gα and RGS protein can be retrieved. The user can also find information regarding diseases that relate to such entries 
as well as information on their tissue distribution. Integrating the information presented above would be useful in inferring the 
relationship between RGS proteins and GPCRs.BMC Genomics 2006, 7:317 http://www.biomedcentral.com/1471-2164/7/317
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tebrate brain that is highly developed in mammals. The
function of hippocampus appears to be related to the
expression of responses that generate emotion and mem-
ory. Thus users may infer that RGS4 is a potential drug tar-
get for Alzheimer's disease. Finally, also using this
database, users can carry out a comprehensive search on
RGS4 including potential inhibitory sites and other bind-
ing partners, which might be needed for further studies.
As the RINGdb contents from the literature increase, more
integrated information can be retrieved simultaneously
and helps users to discover the physiological functions of
RGS proteins and GPCRs more accurately.
Comparison between RINGdb and GPCRDB
The RINGdb differs from the current GPCRDB in many
ways. Firstly, we have integrated the RGS proteins, a fam-
ily of regulators of G-protein signaling, and GPCRs into
RINGdb. Biologists interested in GPCR signaling can
access RGS and GPCR information simultaneously and
conveniently. Secondly, we provide an integrated, classi-
fied and friendly query interface. Users can access infor-
mation faster, more simply and specifically. Thirdly,
RINGdb focuses on clinical research related to GPCR sig-
naling. The medical information about RGS proteins and
GPCRs will have great usefulness in clinical research and
drug discovery.
Discussion
The analysis of several different properties of GPCRs and
RGS simultaneously is useful in discovering new physio-
logical functions that relate to disease. This information
might prove important for the identification of novel drug
targets and disease therapies. From the RINGdb search, we
have found that the RGS domain of RGS1 may bind the
cysteine-rich region of adenomatous polyposis coli pro-
tein (APC protein) which participates in Wnt signaling
pathway. Both of RGS1 and APC co-express in germinal
center B cells. It is likely that RGS1 is able to integrate G
protein signaling and Wnt signaling through its interac-
tion with APC. Furthermore, information from RINGdb
has shown both of RGS1 protein and its known binding
partners, including Gα i1, Gα i2, Gα i3, Gα o1 and α-2A
adrenergic receptor, are present in multiple sclerosis (MS)
lesions, suggesting they may have a role in pathological
conditions. With information obtained from RINGdb, it
is able to integrate useful known data to discover new
putative signaling pathways in diseases. Although these
putative signaling pathways require further experimental
supports, it will indeed facilitate and direct research work.
Conclusion
RINGdb is a novel integrated database providing RGS pro-
tein and GPCR information specifically for clinical
research. Our study not only focuses on integrating all
information related to RGS proteins and GPCRs into a
biological database, but also helps to answer many differ-
ent questions about the both proteins.
Future works
Future prospects of this work include increasing database
contents, in particular by adding information on three-
dimensional protein structures, G-proteins and interac-
tions between drug agents and GPCRs. Also, we intend to
provide tools for visualization and analysis and to identify
novel RGS and GPCR binding partners, thus enhancing
the study of GPCR signaling pathways. Furthermore, we
are planning to incorporate in the database high-precision
data by mining and extract information from the litera-
ture in an automated way. Finally updating the system in
real time is also our objective for future research.
Availability and Requirements
RINGdb: an integrated database for RGS and GPCR
(v1.0). 
This database is now available at http://
ringdb.csie.ncu.edu.tw/ringdb/.
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